research on the rocks

Texas vodka brand doles out $1M grant to Houston research institution for COVID-19 vaccine

Two researchers from Baylor College of Medicine are working on taking their work on a SARS vaccine and adjusting it to target COVID-19 — and they just got $1 million from Tito's Handmade Vodka to keep up their work. Photo via bcm.edu

A vodka distiller based in Austin is sending funds to a Houston research group that's working on a vaccine to fight the coronavirus.

Tito's Handmade Vodka — through its philanthropic arm Love, Tito's — has pledged to give Baylor College of Medicine a $1 million grant to accelerate research on a vaccine for the virus.

Two BCM researchers are taking the work they began in 2011 to develop a SARS vaccine with the intent to make adjustments to target SARS-CoV-2, the virus that causes COVID-19. Dr. Peter Hotez is the dean of the National School of Tropical Medicine at Baylor, and Dr. Maria Elena Bottazzi is the associate dean of the National School of Tropical Medicine. The duo serves as co-directors of the Texas Children's Hospital for Vaccine Development as well.

"Our coronavirus vaccine is designed in Texas and tested in Texas with the utmost priority to ensure it is safe and effective," Bottazzi says in a news release for BCM. "To now see that it will be supported by Texas-based Tito's is a testament that our state will be recognized as being at the forefront of this pandemic, making a difference and reaching all populations locally and globally."

Drs. Hotez and Bottazzi focus on developing vaccines for new or neglected tropical diseases that affect those living in poverty around the world. Along with their partnership with PATH, a global nonprofit organization that will help speed up the vaccine's regulatory phase, the doctors' work from 2011 on SARS is promising and will hopefully help safely and quickly develop a COVID vaccine.

"It's an honor to work with Tito's on this life-saving initiative, which we hope will ultimately lead to a vaccine for America," Hotez says in the release. "Our vision is that it would also advance as a low-cost global health vaccine, now that COVID-19 is racing through Latin American nations, such as Ecuador and Brazil, in addition to South Asia."

Love, Tito's, which is also based in Austin, has contributed to a few other organizations amid the COVID-19 crisis, including: Children of Restaurant Employees (CORE), USBG National Charity Foundation's COVID-19 Relief Campaign, World Central Kitchen, and Southern Smoke Foundation's Emergency Relief Fund, a Houston-based initiative.

"Everything we do at Tito's is rooted in giving back to the communities we serve, and this pandemic is no exception," says Sarah Everett, director of Global Impact and Research at Tito's Handmade Vodka.

"We applaud the worldwide effort to fund and support vaccines that look promising, because we can never know in advance which ones will be effective. We're proud to support Dr. Hotez, Dr. Bottazzi and their team's work to improve humanity's odds of success against COVID-19 and future coronavirus mutations."

Love, Tito's is the nonprofit arm of Tito's Handemade Vodka. Photo via titosvodka.com

Trending News

Building Houston

 
 

Proxima Clinical Research has announced an office expansion — and more Houston innovation news. Photo via Twitter

Houston's innovation ecosystem has had some big news this month, from new job titles for Houston innovators to expanding office space.

In this roundup of Houston startup and innovation news, a Houston organization expands its footprint in the TMC, Rice University opens applications for a cleantech accelerator, and more.

Organization expands footprint in Houston

Proxima CRO has announced its expansion within TMCi. Photo via Twitter

Proxima Clinical Research, a contract research organization headquartered in Houston, announced that it is expanding its office space in the Texas Medical Center Innovation Factory.

"Texas Medical Center is synonymous with innovation, and the TMC Innovation space has proven an ideal location for our CRO. It's an important part of our origin story and a big part of our success," says Kevin Coker, CEO and co-founder of Proxima CRO, in a news release.

The expansion will include around 7,500-square feet of additional office space.

"The resources found across TMC's campuses allow for companies such as Proxima Clinical Research to achieve clinical and business milestones that will continue to shape the future of life sciences both regionally and globally. We are excited for Proxima to expand their footprint at TMC Innovation Factory as they further services for their MedTech customers," says Tom Luby, director of TMC Innovation, in the release.

$20M grant fuels hardtech program's expansion

Activate is planting its roots in Houston with a plan to have its first set of fellows next year. Photo via Activate.org

A hardtech-focused nonprofit officially announced its Houston expansion this week. Activate, which InnovationMap reported was setting up its fifth program here last month, received a $20M commitment by the National Science Foundation to fuel its entrance into the Bayou City.

“Houston’s diversity offers great promise in expanding access for the next generation of science entrepreneurs and as a center of innovation for advanced energy," says NSF SBIR/STTR program director Ben Schrag in a news release.

The organization was founded in Berkeley, California, in 2015 to bridge the gap between the federal and public sectors to deploy capital and resources into the innovators creating transformative products. The nonprofit expanded its programs to Boston and New York before launching a virtual fellowship program — Activate Anywhere, which is for scientists 50 or more miles outside one of the three hubs.

“We are delighted to be opening our newest Activate community in Houston,” says Activate Anywhere managing director Hannah Murnen, speaking at the annual Advanced Research Projects Agency-Energy Innovation Summit. “Houston is a city where innovation thrives, with an abundance of talent, capital, and infrastructure—the perfect setting for the Activate Fellowship.”

Activate is still looking its Houston’s first managing director is actively underway and will select fellows for Activate Houston in 2024.

TMC names new entrepreneur in residence

Zaffer Syed has assumed a new role at TMC. Photo via TMC.org

Houston health tech innovator has announced that he has joined the Texas Medical Center's Innovation Factory as entrepreneur in residence for medtech. Zaffer Syed assumed the new role this month, according to his LinkedIn, and he's been an adviser for the organization since 2017.

Syed has held a few leadership roles at Saranas Inc., a medical device company founded in Houston to detect internal bleeding following medical procedures. He now serves as adviser for the company.

"As CEO of Saranas, he led the recapitalization of the company that led to the FDA De Novo classification and commercial launch of a novel real-time internal bleed monitoring system for endovascular procedures," reads the TMC website. "Zaffer oversaw clinical development, regulatory affairs and strategic marketing at OrthoAccel Technologies, a private dental device startup focused on accelerating tooth movement in patients undergoing orthodontic treatment.

"Prior to working in startup ventures, Zaffer spent the first 13 years of his career in various operational roles at St. Jude Medical and Boston Scientific to support the development and commercialization of Class III implantable devices for cardiovascular and neuromodulation applications."

TMC is currently looking for an entrepreneur in residence for its TMCi Accelerator for Cancer Therapeutics program.

Applications open for clean energy startup program

Calling all clean energy startups. Photo courtesy of The Ion

The Clean Energy Accelerator, an energy transition accelerator housed at the Ion and run by the Rice Alliance for Technology and Entrepreneurship, has opened applications for Class 3. The deadline to apply is April 14.

The accelerator, which helps early-stage ventures reach technical and commercial milestones through hybrid programming and mentorship, will host its Class 3 cohort from July 25 to Sept. 22.

“Accelerating the transition to a net-zero future is a key goal at Rice University. Through accelerating the commercial potential of our own research as well as supporting the further adoption of global technologies right here in Houston, the Rice Alliance Clean Energy Accelerator is proof of that commitment,” says Paul Cherukuri, vice president of innovation at Rice, in a news release. “The Rice Alliance has all the critical components early-stage energy ventures need for success: a corporate innovation network, energy investor network, access to mentors and a well-developed curriculum. This accelerator program is a unique opportunity for energy startups to successfully launch and build their ventures and get access to the Houston energy ecosystem.”

According to Rice, the 29 alumni companies from Class 1 and 2 have gone on to secure grants, partnerships, and investments, including more than $75 million in funding. Companies can apply here, learn more about the accelerator here or attend the virtual information session April 3 by registering here.

Trending News